Navigation Links
Advanced Wound Care Market is Expected to Reach $12,454 Million, Globally by 2022 - Allied Market Research
Date:3/17/2017

PORTLAND, Oregon and PUNE, India, March 17, 2017 /PRNewswire/ --

Advanced Wound Care Market (AWC Market) Report, published by Allied Market Research, forecasts that the global market is expected to garner $12,454 million by 2022, registering a CAGR of 8.3% during the period 2016-2022. Active wound care is projected to be the dominant segment by 2022. North America is estimated to maintain its lead position throughout the forecast period with around two-fifths share in 2015.

Continue Reading
Allied Market Research Logo
Allied Market Research Logo

     (Logo: http://photos.prnewswire.com/prnh/20140911/647229)

Major factors that boost the market growth include the change in lifestyle conditions that lead to increased diabetic wounds and pressure ulcers, technological advancements, favorable reimbursement scenario in developed economies, and increase in adoption rate of advanced wound care products. Moreover, there is a positive correlation between aged population and frequent occurrences of severe chronic & surgical wounds. High unmet medical needs and rise in preference for products that enhance therapeutic outcome are anticipated to drive the demand for these products. However, high cost of products and unfavorable reimbursement policies in the emerging countries restrict the market growth.

Summary of the Advanced Wound Care Market can be accessed on the website at: https://www.alliedmarketresearch.com/advanced-wound-care-market

The therapy devices segment is estimated to lead in 2016 closely followed by exudate management. Therapy devices enhance the healing process with the use of vacuum dressing for acute and chronic wounds; hence, rise in incidences of chronic infections such as diabetic foot ulcers and pressure ulcers are expected to boost the market growth. Active wound care is estimated to grow at the fastest rate due to its low toxicity and biocompatibility characteristics, which facilitate active wound care products as attractive and effective.

In the end user segment, community centers accounted for a major market share in 2015, and is projected to maintain this trend throughout the forecast period. This is attributed to the increase in adoption rate of high technology solutions and the availability of wide range of AWC products coupled with government reimbursements. Community centers are followed by hospitals with over two-fifths share of the overall market in 2015.

Geographically, North America occupied a major market share in 2015, and is expected to continue this trend. This was attributed to an increase in the diabetic population, presence of highly sophisticated healthcare infrastructure, and adoption of AWC products. However, Asia-Pacific followed by LAMEA are expected to be the fastest growing regions, due to ample growth opportunities in terms of unmet medical needs for the treatment of wounds.

Key findings of the Advanced Wound Care Market: 

  • Therapy device was the leading segment in 2015, and is projected to grow at a CAGR of 4.3% during the forecast period.
  • The active wound care segment is estimated to grow at a CAGR of 20.6%.
  • The chronic wounds application segment is expected to grow at the fastest CAGR of 8.8%.
  • Community center segment is projected to grow at a CAGR of 11.1% in the Asia-Pacific region.
  • U.S. was the largest country in 2015, and is projected to maintain its lead position until 2022.

China and Japan are the major shareholders, jointly accounting for almost two-fifths share of the Asia-Pacific market, in 2015.

Key players in this market adopted product development and launches as their key strategies. They launched economical and technologically efficient products to strengthen their market position. The key players profiled include 3M Company, Smith & Nephew plc, Coloplast A/S, Medtronic plc, Acelity L.P. Inc., ConvaTec Healthcare B.S..r.l., Mlnlycke Health Care AB, BSN Medical GmbH, Alliqua BioMedical, Inc., and Integra LifeSciences Holdings Corporation.  

Read similar market research reports on Diagnostics and Biotech at: https://www.alliedmarketresearch.com/life-sciences/diagnostic-and-biotech-market-report

About Us: 

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions". AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:
Rahul Thakur
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Direct: +1-503-894-6022
Toll Free: +1 (800) 792-5285 (U.S. & Canada)
Fax: +1 (855) 550-5975
E-mail: sales@alliedmarketresearch.com

Website: https://www.alliedmarketresearch.com



'/>"/>
SOURCE Allied Market Research
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. ASCO 2013: Boehringer Ingelheim to Present Data Across Multiple Cancers, Including Different Treatment Settings for Advanced NSCLC
2. Boehringer Ingelheim Presents Progression-Free Survival Data for Investigational Afatinib and Nintedanib in Advanced NSCLC
3. Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine
4. Advanced Prenatal Therapeutics - Using Targeted Apheresis to Treat Preeclampsia
5. Cempra Awarded $58 Million Contract to Develop Antibiotic for Pediatric Use and Biodefense by Biomedical Advanced Research and Development Authority (BARDA)
6. New Prefillable Syringe System Offers Advanced Glass Technology for Biopharmaceutical Injectable Drug Delivery
7. Merrimack Pharmaceuticals Phase 1 Research Supports MM-121 Potential For Investigation As Combination With Chemotherapy In Patients With Advanced Solid Tumors
8. New Air Products Microsite Features Advanced Liquid Nitrogen Solutions for the Chemical, Pharmaceutical, and Life Science Industries
9. Emerging Targeted Therapies Offer Efficacy Advantages Over Currently Used Chemotherapies for Platinum-Resistant Advanced Ovarian Cancer
10. Ochsner Health System Improves Safety Through Advanced Medication Management Technology
11. New drug proving effective in attacking advanced prostate cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2021)... ... March 29, 2021 , ... The University of Texas Health Science Center ... San Antonio Multispecialty and Research Hospital, a destination center for research and treatment of ... In a nod to the COVID-19 pandemic, the ceremony was held virtually. , William ...
(Date:3/30/2021)... ... March 29, 2021 , ... Iora Health ... primary care, has partnered with Devoted Health , one of the fastest-growing ... across Maricopa County and provides seniors with the highest-quality care and experience possible, ...
(Date:3/30/2021)... CITY (PRWEB) , ... March 29, 2021 , ... ... has joined the Vaccine Credential Initiative (VCI), a group bringing together leading health ... record of vaccination status, based on open, interoperable standards. By joining the VCI ...
Breaking Medicine Technology:
(Date:3/30/2021)... , ... March 29, 2021 , ... ... the 21st Century , A Virtual Workshop Presented by WCG FDAnews and Cerulean ... 4:30 pm EDT, https://wcg.swoogo.com/modern-sop-and-quality-systems , Are one’s SOPs written for the ...
(Date:3/30/2021)... ... March 29, 2021 , ... According to data released ... reproductive age (13-44) in need of publicly funded contraception live in counties impacted by ... Colorado’s 64 counties have lost some of their Title X resources. , The ...
(Date:3/30/2021)... ... March 29, 2021 , ... Health Literacy Innovations (HLI), a ... confusion due to low health literacy today announces a new partnership with the ... work with ACAP’s member Safety Net Health Plans, those that provide comprehensive health ...
(Date:3/30/2021)... ... ... Dr. Colin Campbell is proud to announce the 1 year anniversary in their new state ... internal medicine and is a primary care specialist who has been practicing for 23 years. ... keep South Jersey healthy one patient at a time. , “Over the past year, Dr. ...
(Date:3/30/2021)... ... March 30, 2021 , ... The COVID-19 ... and survivors; their families; and their caregivers. Crossroads4Hope is addressing the needs of ... emotional support system, MyGo2Support, which meets needs of people impacted by cancer, no ...
Breaking Medicine News(10 mins):